Note: Ingredients listed on restricted chemical lists
EC/CAS
9004-65-3
Name of the chemical
methylhydroxypropylcellulose
Concentration
2.4572
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
1.0962
General Information
Revision date
2021-08-06
Product name
PAROXETINE TABLETS
Product Synonyms
PAROXETINE 10MG TABLETS * PAROXETINE 20MG TABLETS * PAROXETINE 30MG
1.2.2. Uses advised against
No other uses are advised
Emergency telephone
+(1) 760 476 3971, +(1) 760 476 3962, +(1) 866 519 4752
Icons in SDS
Company Information
company name
GlaxoSmithKline
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H318, H361, H372
Hazard statements
Code
Statements
H318
Causes serious eye damage
Section 2
SECTION 2: Hazards identification
Physical hazards
Not classified.
Health hazards
Serious eye damage/eye irritation Category 1 Reproductive toxicity (fertility, the unborn Category 2 child) Specific target organ toxicity following Category 1 (bones) repeated exposure
Environmental hazards
Not classified.
Signal word
Danger
Hazard statements
H318 Causes serious eye damage. H361 Suspected of damaging the unborn child. H361 Suspected of damaging fertility. H372 Causes damage to organs (bones) through prolonged or repeated exposure.
Prevention
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P260 Do not breathe dust/fume/gas/mist/vapours/spray. P264 Wash thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P280 Wear protective gloves/protective clothing/eye protection/face protection.
Response
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P310 Immediately call a POISON CENTRE or doctor/physician.
Storage
P405 Store locked up.
Disposal
P501 Dispose of contents/container in accordance with local/regional/national/international regulations.
Other hazards which do not result in classification
Assume that this material is capable of sustaining combustion. Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
Additional information
12.5534 % of the mixture consists of component(s) of unknown acute dermal toxicity. 6.1534 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 6.1534 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment. National/local information Not available
